Dynavax Technologies | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
AbbVie USD 1.46B 1.86B 2025-03
Adma Biologics USD 349.02M 117.13M 2024-12
Amgen USD 7.43B 1.22B 2025-06
AstraZeneca USD 44.72B 3.68B 2025-06
Biogen USD 17.63B 655.3M 2025-06
BioMarin Pharmaceutical USD 6.03B 233.65M 2025-06
Bristol-Myers Squibb USD 17.49B 100M 2025-06
Dynavax Technologies USD 494.16M 36.78M 2025-06
Gilead Sciences USD 19.67B 596M 2025-06
Glaxosmithkline GBP 13.67B 337M 2024-12
Merck USD 49.06B 725M 2025-06
Neurocrine Biosciences USD 2.69B 158.6M 2025-06
Novartis USD 42.05B 3.6B 2025-06
Pfizer USD 88.7B 1.64B 2025-06
Regeneron Pharmaceuticals USD 29.94B 551.3M 2025-06
Roche Holding CHF 36.16B 3.28B 2024-12
Sarepta Therapeutics USD 1.36B 214.66M 2025-06
TG Therapeutics USD 276.43M 39.14M 2025-06
Vertex Pharmaceuticals USD 17.18B 679.1M 2025-06


Dynavax Technologies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.